composition
Retino-A cream 0.05% (Tretinoin) is available in a 20g tube
and is manufactured by Janssen-Cilag (India).
description
Tretinoin is a vitimin a derivative. Tretinoin enhances cell
and vascular proliferation and is therefore a great exfoliator
of the skin. Tretinoin works by altering the follicular epithelium
( the outer layer of the skin ) so that it does not keratinize
( form a hard compact layer ). When used in cojunction with
topical minoxidil, this attribute has the effect of dramatically
increasing the penetration and absorbsion rate of the minoxidil
maximising the beneficial effects.
indications.
Topical Retino-A can be used for the following conditions
:
1. To enhance the absorbsion of topical minoxidil
for the treatment of hair loss / alopecia.
2. To help diminish the visible signs of
aging and reduce lines on the face and age spots.
3. To treat the condition known as acne vulgaris.
This website is primarily concerned with the beneficial effects
that Retino-A ( Tretinoin ) exerts on hair loss. Retino-A
used on its own can result in moderate hair regrowth in some
patients. However, when used in conjunction with topical minoxidil,
Retino-A enhances the penetration and absorbsion of the minoxidil.
This is probably due to the fact that by preventing keratinization,
Retino-A decreases the protective barrier of the skin allowing
greater absorbsion of medications that are put into direct
contact with the skin. One particular study showed a threefold
absorbsion rate of topical minoxidil when used in conjunction
with 0.05% Tretinoin as compared with the controlled group.
dosage / administration
As Tretinoin is best used in conjunction with topical minoxidil
solution, Retino-A should be applied prior to the twice daily
application of minoxidil. The cream should be applied evenly
using a guaze swab or the tips of clean fingers. Since Retino-A
can cause some skin irritation, it is important to apply it
carefully at first to guage reaction. If acceptable irritation
is experienced, Retino-A can be applied to the required areas.
Retino-A may cause a transitory feeling of warmth or slight
stinging and may also produce a slight erythema similar to
mild sunburn. It has been reported that aloe vera can soothe
any irritation caused by Tretinoin therefore this could prove
a worthwhile addition to treatment involving Retino-A. Excess
application of Retino-A does not provide more rapid or better
results. In fact, marked redness, peeling or discomfort can
occur. If excess application occurs, Retino-A should be discontinued
for several days before resuming therapy.
side effects
Some degree of local irritation is expected. The most commonly
reported undisirable effects are skin, burning, stinging,
warmth, erythema, pruritus, rash, peeling, and temporary hypo
and hyperpigmentation. Rarely reported undesirable effects
are blistering and crusting of the skin, eye irritation and
edema. These reactions are usually mild to moderate in severity,
generally well tolerated and self limiting, occuring during
the early course of therapy and generally decreasing over
time with the exception of dry skin, which tends to persist.
True contact allergy to topical Tretinoin is rarely encountered.
warnings and precautions
In order to minimize the potential for additional skin irritation,
care should be taken to avoid contact with the eyes, eyelids,
angles of the nose, mouth, mucous membranes or other areas
where treatment is not intended. Retino-A can increase sensitivity
to sunlight, including ultravoilet lamps, so particular caution
should be exercised if subject to prolonged exposure to ultravoilet
light. When exposure to sunlight cannot be avoided, use of
sunscreen products and protective clothing over treated areas
is recommended. No adequate and well controlled prospective
studies have been performed with pregnant women exposed to
topical Tretinoin to date. However, a well-conducted retrospective
cohort study of babies born to women exposed to topical Tretinoin
during the first trimester of pregnancy found no excess birth
defects amongst these babies when compared with babies born
to women in the same cohort who were not similarly exposed.
Therefore, topical Tretinoin should be used during pregnancy
only if the potential benefit justifies the potential risk
to the fetus. Also, it is not known if Tretinoin is excreted
in human milk. Therefore, caution should be exercised when
Retino-A is administered to a nursing mother. Safety and effectiveness
have not been established with regard to use of Retino-A by
children, therefore medical advice should be sought.
drug interactions
Abrasive soaps, cleansers,medicated creams or lotions,soaps
and cosmetics that have a strong drying effect, and products
with high concentrations of alcohol, astringents, spices or
lime can increase skin irritation. Particular caution should
be exercised in using preparations containing sulphur, resorcinol,
or salicylic acid with Retino-A. It is also advisable to 'rest'
a patients skin until the effects of such preparations subside
before use of Retino-A is begun. |